← Back to Clinical Trials
Recruiting NCT05906472

NCT05906472 PUSH-IT Continuing Enteral Feeds for Tracheostomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05906472
Status Recruiting
Phase
Sponsor State University of New York at Buffalo
Condition Tracheostomy Complication
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2023-02-06
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Feeds continuedFeeds held

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2023-02-06 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to evaluate nutrition administration in the time around the tracheostomy in patients with breathing tubes. The main questions it aims to answer are: * Will continuing nutrition up to the time of surgery (tracheostomy) decrease nutrition interruptions, thereby increasing food intake? * Does continuing nutrition up to the time of surgery increase instances of food going into the lungs or lung infections? Researchers will compare patients who have nutrition withheld 6 hours prior to surgery versus those who receive nutrition up until the time of surgery to see if there are differences in food intake, instances of food entering the lungs or lung infections.

Eligibility Criteria

Inclusion Criteria: * 18 years or older * admitted to the intensive care unit (ICU) * intubated and require tracheostomy Exclusion Criteria: * under 18 years * unable to obtain informed consent * deemed clinically brain dead within 7 days of enrollment * transitioned to comfort measures within 7 days of enrollment * Pregnant patients * Prisoners

Contact & Investigator

Central Contact

Eden Nohra, MD

✉ edennohra@gmail.com

📞 3144439727

Principal Investigator

Marcy Jordan, PhD

STUDY DIRECTOR

University at Buffalo

Frequently Asked Questions

Who can join the NCT05906472 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Tracheostomy Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05906472 currently recruiting?

Yes, NCT05906472 is actively recruiting participants. Contact the research team at edennohra@gmail.com for enrollment information.

Where is the NCT05906472 trial being conducted?

This trial is being conducted at Danbury, United States, West Palm Beach, United States, Kansas City, United States, Buffalo, United States and 2 additional locations.

Who is sponsoring the NCT05906472 clinical trial?

NCT05906472 is sponsored by State University of New York at Buffalo. The principal investigator is Marcy Jordan, PhD at University at Buffalo. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology